Scripps director: Validation needed to unlock the potential of wearables

Scripps Translational Science Institute's digital medicine program director Steven Steinhubl has said validation of wearables is needed to unlock their considerable potential. Steinhubl thinks wearables could upend several areas of healthcare, but the devices will only enter the mainstream once there is clinical evidence of potential benefits. Developers are increasingly aware of the need to generate such evidence. Article | More

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.